Pathogenic germline variants in 10,389 adult cancers K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ... Cell 173 (2), 355-370. e14, 2018 | 702 | 2018 |
Comprehensive genomic characterization of upper tract urothelial carcinoma TJ Moss, Y Qi, L Xi, B Peng, TB Kim, NE Ezzedine, ME Mosqueda, ... European urology 72 (4), 641-649, 2017 | 196 | 2017 |
Sequential therapy with PARP and WEE1 inhibitors minimizes toxicity while maintaining efficacy Y Fang, DJ McGrail, C Sun, M Labrie, X Chen, D Zhang, Z Ju, CP Vellano, ... Cancer cell 35 (6), 851-867. e7, 2019 | 180 | 2019 |
Sarcomatoid renal cell carcinoma has a distinct molecular pathogenesis, driver mutation profile, and transcriptional landscape Z Wang, TB Kim, B Peng, J Karam, C Creighton, A Joon, F Kawakami, ... Clinical Cancer Research 23 (21), 6686-6696, 2017 | 83 | 2017 |
Comprehensive genomic profiling of metastatic squamous cell carcinoma of the anal canal V Morris, X Rao, C Pickering, WC Foo, A Rashid, K Eterovic, T Kim, ... Molecular Cancer Research 15 (11), 1542-1550, 2017 | 69 | 2017 |
Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer F Meric-Bernstam, X Zheng, M Shariati, S Damodaran, C Wathoo, ... JCO precision oncology 2, 1-15, 2018 | 63 | 2018 |
Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma R Ruiz-Cordero, P Rao, L Li, Y Qi, D Atherton, B Peng, RR Singh, TB Kim, ... Modern Pathology 32 (11), 1698-1707, 2019 | 45 | 2019 |
Distinct biological types of ocular adnexal sebaceous carcinoma: HPV-driven and virus-negative tumors arise through nonoverlapping molecular-genetic alterations MT Tetzlaff, JL Curry, J Ning, O Sagiv, TL Kandl, B Peng, D Bell, ... Clinical Cancer Research 25 (4), 1280-1290, 2019 | 45 | 2019 |
Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers B Garmezy, J Gheeya, HY Lin, Y Huang, T Kim, X Jiang, KZ Thein, ... JCO Precision Oncology 6, e2100267, 2022 | 41 | 2022 |
Phase Ib dose expansion and translational analyses of olaparib in combination with capivasertib in recurrent endometrial, triple-negative breast, and ovarian cancer SN Westin, M Labrie, JK Litton, A Blucher, Y Fang, CP Vellano, ... Clinical Cancer Research 27 (23), 6354-6365, 2021 | 33 | 2021 |
Use of targeted next-generation sequencing to identify activating hot spot mutations in cherry angiomas N Klebanov, WM Lin, M Artomov, M Shaughnessy, CN Njauw, R Bloom, ... JAMA dermatology 155 (2), 211-215, 2019 | 29 | 2019 |
Genomic, transcriptomic, and proteomic profiling of metastatic breast cancer A Akcakanat, X Zheng, CX Cruz Pico, TB Kim, K Chen, A Korkut, A Sahin, ... Clinical Cancer Research 27 (11), 3243-3252, 2021 | 21 | 2021 |
Cancer driver mutation prediction through Bayesian integration of multi-omic data Z Wang, KS Ng, T Chen, TB Kim, F Wang, K Shaw, KL Scott, ... PLoS one 13 (5), e0196939, 2018 | 20 | 2018 |
A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries OL Veeranki, Z Tong, A Mejia, A Verma, R Katkhuda, R Bassett, TB Kim, ... Disease models & mechanisms 12 (12), dmm041004, 2019 | 17 | 2019 |
Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy options M Labrie, TB Kim, Z Ju, S Lee, W Zhao, Y Fang, Y Lu, K Chen, P Ramirez, ... Oncotarget 10 (37), 3533, 2019 | 17 | 2019 |
T2R bitter taste receptors regulate apoptosis and may be associated with survival in head and neck squamous cell carcinoma RM Carey, DB McMahon, ZA Miller, TB Kim, K Rajasekaran, I Gopallawa, ... Molecular oncology 16 (7), 1474-1492, 2022 | 16 | 2022 |
Existence of a unique solution to a nonlinear moving-boundary problem of mixed type arising in modeling blood flow S Čanić, A Mikelić, TB Kim, G Guidoboni Nonlinear Conservation Laws and Applications, 235-256, 2011 | 14 | 2011 |
Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta‐analysis MK Nowakowska, T Kim, MT Thompson, KL Bolton, A Deswal, SH Lin, ... American journal of hematology 97 (4), 411-420, 2022 | 13 | 2022 |
Incorporating ENCODE information into association analysis of whole genome sequencing data T Kim, P Wei BMC proceedings 10, 257-261, 2016 | 11 | 2016 |
Qualitative properties and approximation of solutions of Bingham flows: on the stabilization for large time and the geometry of the support JI Díaz, R Glowinski, G GuIDoboni, T Kim RACSAM-Revista de la Real Academia de Ciencias Exactas, Fisicas y Naturales …, 2010 | 10 | 2010 |